This guideline covers how to improve services for people aged 14 and above who have been diagnosed as having coexisting severe mental illness and substance misuse. The aim is to provide a range of coordinated services that address people’s wider health and social care needs, as well as other issues such as employment and housing (NICE)
Bibliography: Interventions – Treatment
Shooting Up: infections among people who inject drugs in the UK
This Public Health England report describes the extent of infections among people who inject drugs (PWID) in the United Kingdom
Health and Justice Commissioning Intentions 2017/18 (PDF)
This document sets out NHS England’s national commissioning intentions for healthcare services in secure and detained settings, sexual assault referral centres and liaison and diversion for 2017/18 (NHS England)
Health and Justice Commissioning Intentions 2017/18
This document sets out the purpose of the document and context of commissioning in a fast changing environment (NHS England)
Substance misuse statistics from NDTMS: financial year ending March 2016
National Drug Treatment Monitoring System (NDTMS) annual publication of alcohol and drug treatment activity statistics for adults in England (Public Health England)
Physical health of people in prison
NICE guideline [NG57]
We must escalate efforts to prevent drug-related deaths
Deaths caused by drug misuse are rising. In order to help us take effective action we need to better understand the multiple and complex causes behind this disturbing trend (Public Health England)
Public Health England Health & Justice annual review 2015/16 (PDF)
4.3 Preventing and reducing substance misuse in the CJS
Draft from Consultation on Professional Standards for optimising medicines for people in secure environments (PDF)
Immigration Removal Centres, Prisons and other places of residential detention (Royal Pharmaceutical Society)
National Drug and Alcohol Treatment Waiting Times Report (PDF)
This publication presents data from the Drug and Alcohol Treatment Waiting Times database (DATWT). It includes details on the number of people waiting, the time waited to start drug or alcohol treatment, and information on specific interventions being accessed (NHS Scotland)
How can contingency management support treatment for substance use disorders? A systematic review (PDF)
This EMCDDA Paper contains a systematic review of studies on the effectiveness of contingency management when used alongside the pharmacological treatment of dependence
Drug-Related Hospital Statistics Scotland 2015/16 (PDF)
This release from the Information Services Division reports on hospital stays in relation to a drug misuse diagnosis and the patients admitted to hospital for such treatment. This report describes the number of drug-related hospital stays, the number and characteristics of patients admitted to hospital, the substances involved and the geographical variations within Scotland (NHS Scotland)
Taking away the chaos (PDF)
The health needs of people who inject drugs in public places in Glasgow city centre (NHS)
Alcohol and drug prevention, treatment and recovery for adults: planning interventions
Good practice prompts for planning comprehensive interventions in 2016 and 2017, to be used by local healthcare commissioners (Public Health England)
Exploring drug treatment and homelessness in Australia: 1 July 2011 to 30 June 2014
There is much research to suggest a considerable overlap between people experiencing precarious housing, and drug and alcohol misuse. Linking client data from specialist homelessness services and alcohol and other drug treatment services, this report provides a picture of the intersection of these two issues on a national scale (AIHW)
A Healthier Start: Addressing Neonatal Abstinence Syndrome and Opioid Misuse during Pregnancy
In collaboration with partners across federal government, SAMHSA is sharpening its focus on opioid-dependent pregnant women. And with a $1 billion, two-year investment of new, mandatory funding in the President’s Fiscal Year (FY) 2017 Budget proposal to bolster our efforts, we’re expanding and intensifying our work to prevent and treat opioid dependence, including identification and treatment of NAS
New Psychoactive Substances (NPS) resource pack
A resource pack on new psychoactive substances for educators and practitioners working with young people (Home Office)
Hepatitis C among drug users in Europe: epidemiology, treatment and prevention
A state of the art review of the epidemiology of hepatitis C virus (HCV) infection in Europe and an overview of the way preventive measures are currently implemented in European countries set the scene (EMCDDA)
Families Affected by Parental Substance Use
The purposes of this clinical report are to review some of the short-term effects of maternal substance use during pregnancy and long-term implications of fetal exposure; describe typical medical, psychiatric, and behavioral symptoms of children and adolescents in families affected by substance use; and suggest proficiencies for pediatricians involved in the care of children and adolescents of families affected by substance use, including screening families, mandated reporting requirements, and directing families to community, regional, and state resources that can address needs and problems (Pediatrics)
Health responses to new psychoactive substances
This short report provides an overview of the current situation in terms of NPS use and harms across Europe and reviews the available health- and drug-related interventions in that area (EMCDDA)
New Psychoactive Drugs: No Easy Answer
This paper will advance policymakers’ knowledge and thinking about this developing issue (Policy Talk)
Exploring the effects criminal history and socioeconomic status have on racial and ethnic disparities in substance use treatment
How do criminal history and socioeconomic status relate to racial and ethnic disparities in substance use treatment? (BASIS)
Patient motivations, perceptions and experiences of opioid substitution therapy in prison
Our findings have highlighted the challenges facing opioid treatment providers in prison in addressing patient ambivalence towards OST and preferences to cease OST prior to release, and can inform the development of policies and clinical practices that are mindful of patient perspectives and concerns (NDARC)
Emerging consensus on measuring addiction recovery
Findings from a multi-stakeholder consultation exercise (Drugs: Education, Prevention and Policy)
Emergency department-based brief interventions for individuals with substance-related problems: a review of effectiveness
This paper considers five systematic reviews and 16 randomised controlled trials and points to the potential benefits of brief interventions, albeit with a need for more research (EMCDDA
The extent and nature of addiction to medicines in Cheshire and Merseyside
The aim of this study was, therefore, twofold: (1) to investigate health professionals’ experiences of ATM and (2) their understanding of optimally identifying and addressing ATM (CPH)
How can opioid substitution therapy be optimised to maximise recovery outcomes for service users?
The second and concluding report on opioid substitution therapy from the Advisory Council on the Misuse of Drugs (ACMD)
Wales – Substance misuse statistics
These reports include statistics from the Welsh National Database for Substance Misuse and additional substance misuse related information available from routinely published sources in Wales (Welsh Government)
HIV and young people who inject drugs
Technical brief (WHO)
Factors affecting repeated cessations of injecting drug use and relapses during the entire injecting career among the Edinburgh Addiction Cohort
OST was associated with reduced time to cessation, and there was some suggestion of increased time to relapse too. The likelihood of prolonged cessation is greater for women, increases with age, and decreases with time since last relapse (Drug and Alcohol Dependence)
Drug-Related Hospital Statistics Scotland
This publication reports on hospital stays in relation to a drug misuse diagnosis and the patients admitted to hospital for such treatment (ISD)
PHE announces new capital funding for drug and alcohol recovery services
Public Health England has today announced the availability of £10 million of capital funding for services that are helping people in England with drug or alcohol problems to recover from their addiction
Naloxone – what the new legislation changes mean
Kate Halliday, SMMGP Programme Lead, discusses the recent legislation changes which make naloxone more readily available for those that need it (SMMGP)
New NDARC resource provides heroin dependence treatment information
A new information kit developed by researchers at the National Drug and Alcohol Research Centre at UNSW provides a step by step guide to the evidence for medically assisted treatment for heroin dependence as well as answering commonly asked questions (NDARC )
Drug misuse and dependence: UK guidelines on clinical management
Feedback received (Public Health England)
Medications to treat opioid use disorders
New guideline from the American Society of Addiction Medicine (EurekAlert)
David Best: Why the UK lags behind in recovery for drug users
It’s rare that you’ll see Blackpool praised by a professor of criminology, but when it comes to leading the way in changing how the powers that be handle recovery from substance abuse and dependency, it is certainly a shining example of success
Homelessness: an unhealthy state
Mental health issues were very common, with over half reporting a diagnosis of depression. Almost half of the sample had both a mental health problem and an addiction problem (Partnership for Health Equality, Ireland)
Recovery
Phoenix launches new report describing how communities can work together to provide friendly environments for people in recovery
Joint Strategic Needs Assessment resources for alcohol, drugs and tobacco
PHE has published the latest alcohol, drugs and tobacco joint strategic needs (JSNA) resource pack to help local areas develop joint strategic needs assessments and local joint health and wellbeing strategies that effectively address public health issues relating to alcohol, drug and tobacco use
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- Next Page »
